Is a complete INKT research report available?

No complete published report is available for MiNK Therapeutics, Inc. (INKT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

MiNK Therapeutics, Inc. (INKT)

NASDAQ: INKT · USD

$10.6

+0.21 (+2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INKT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	52.8M
Net income (ttm)	-12.5M
EPS (ttm)	-$2.78
Shares out	5M
Volume	5,839
Beta	0.48
Price target	$39.0	+268.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -12.5M
EPS (ttm): -$2.78
Market cap: 52.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INKT indicators

Market & fundamental data

Available fields

166

Groups with data

Currency

USD

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001840229
Company name	MiNK Therapeutics, Inc.
Country	United States
Country code	US
Cusip	603693201
Employees	15
Employees Change	-8%
Employees Change Percent	-34.78
Enterprise value	$43.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-15
Isin	US6036932019
Last refreshed	2026-07-31
Market cap	$52.8M
Market cap category	Micro-Cap
Price	$10.59
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	INKT
Website	https://minktherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.64%
FCF yield	-11.97%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-12.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-831,329
ROA	-110.9
Roa5y	-88.25
ROCE	-415.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.61%
Cagr3y	-15.09%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$10.4M
Cash	$9.5M
Current Assets	$10M
Current Liabilities	$7.3M
Debt	$0
Equity	$-12.7M
Liabilities	$23.1M
Long Term Assets	$354,518
Long Term Liabilities	$15.8M
Net Cash	$9.5M
Net Cash By Market Cap	$18.06
Tangible Book Value	$-12.7M
Tangible Book Value Per Share	$-2.55
WACC	6.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Net Working Capital	$-6.8M
Quick ratio	1.31
Working Capital	$2.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.88%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.59%
200-day SMA	11.7
3Y total return	-38.79%
50-day SMA	11.41
50-day SMA vs 200-day SMA	50under200
All Time High	221.6
All Time High Change	-95.22%
All Time High Date	2021-11-01
All Time Low	4.56
All Time Low Change	132.24%
All Time Low Date	2025-01-28
ATR	0.62
Beta	0.48
Beta1y	1.96
Beta2y	0.1
Ch YTD	-5.02
High	10.75
High52	18.17
High52 Date	2025-08-15
High52ch	-41.71%
Low	10.4
Low52	8.48
Low52 Date	2026-03-24
Low52ch	24.88%
Ma50ch	-7.16%
Price vs 200-day SMA	-9.46%
RSI	45.17
RSI Monthly	33.66
RSI Weekly	46.13
Sharpe ratio	-0.2x
Sortino ratio	-0.25
Total Return	-14.88%
Tr YTD	-5.02
Tr1m	-11.08%
Tr1w	2.22%
Tr3m	-10.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.6
Operating Income	$-13M
Price target	$39
Price Target Change	$268

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,952,198%
Float Percent	39.19%
Net Borrowing	-5,000,000
Shares Insiders	17.11%
Shares Institutions	2.54%
Shares Out	4,981,899
Shares Qo Q	2.38%
Shares Yo Y	14.88%
Short Float	5.1%
Short Ratio	5.81
Short Shares	2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9M
Adjusted OCF	-9,030,183
Average Volume	12,313.85x
Bv Per Share	-2.55
Ch1m	-11.08
Ch1w	2.22
Ch1y	-36.59
Ch3m	-10.33
Ch3y	-38.79
Ch6m	-13.52
Change	2.02%
Change From Open	1.83
Close	10.38
Days Gap	0.19
Depreciation Amortization	167,046
Dollar Volume	61,835
Earnings Date	2026-08-14
Earnings Time	bmo
EBIT	$-12.8M
EBITDA	$-12.7M
EPS	$-2.78
F Score	2
FCF	$-6.3M
FCF EV Yield	-14.61x
FCF Per Share	$-1.27
Financing CF	12,620,491
Fiscal Year End	December
Founded	2,017
Ipr	-11.75
Iprfo	-91.2
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2025-01-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	11.34
Ma150ch	-6.65%
Ma20	10.88
Ma20ch	-2.68%
Net CF	6,290,777
Next Earnings Date	2026-08-13
Open	10.4
Optionable	No
Position In Range	54.29
Ppne	354,518
Price Date	2026-07-30
Relative Volume	0.47x
Share Based Comp	2,713,294
Tr6m	-13.52%
Us State	New York
Volume	5,839

MiNK Therapeutics, Inc. (INKT)

Coverage state: Market snapshot only — no published research

Generate the first INKT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INKT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INKT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INKT

Frequently asked questions